Leaderboards/Pneumonia and Respiratory Infections

Pneumonia and Respiratory Infections

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Marta Bertran
National Institute for Public Health and the Environment
2
Madhurananda Pahar
Stellenbosch University
3
Anne Christine Nordholm
Statens Serum Institut
4
Corinna Ernst
Luxembourg Institute of Health
5
Margaret M. C. Lam
Monash University
6
Covadonga Pérez-García
Instituto de Salud Carlos III
7
Daan Van Brusselen
University of Antwerp
8
Yanping Li
Jiangsu Vocational College of Medicine
9
Dagfinn Lunde Markussen
Haukeland University Hospital
10
Danielle Moulia
Centers for Disease Control and Prevention

Papers

1
Publication in Eurosurveillance (2024) [135 citations, W4391258475]
Eurosurveillance|2024
135 cit.
2
Invasive pneumococcal disease 3 years after introduction of a reduced 1 + 1 infant 13-valent pneumococcal conjugate vaccine immunisation schedule in England: a prospective national observational surveillance study
The Lancet Infectious Diseases|2024
123 cit.
3
Mycoplasma pneumoniae epidemic in Denmark, October to December, 2023
Eurosurveillance|2024
88 cit.
4
Publication in JAMA Network Open (2024) [87 citations, W4392505213]
JAMA Network Open|2024
87 cit.
5
Publication in Infection and Drug Resistance (2024) [80 citations, W4392964934]
Infection and Drug Resistance|2024
80 cit.
6
Publication in Journal of Infection (2024) [61 citations, W4399814576]
Journal of Infection|2024
61 cit.
7
Pertussis epidemic in Denmark, August 2023 to February 2024
Eurosurveillance|2024
57 cit.
8
Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024
Eurosurveillance|2024
44 cit.
9
Examining the role of Acinetobacter baumannii plasmid types in disseminating antimicrobial resistance
npj Antimicrobials and Resistance|2024
38 cit.
10
Genomic and functional analysis of rmp locus variants in Klebsiella pneumoniae
Genome Medicine|2025
21 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Nicholas J. Croucher
Wellcome Sanger Institute
2
Weiyong Liu
Tongji Hospital
3
Lingling Mao
Jiangsu University
4
Quan-E Chang
Unknown
5
Jessica R. MacNeil
Centers for Disease Control and Prevention
6
Sertan Serte
Near East University
7
Vishvanath Tiwari
Central University of Rajasthan
8
Polycarp Shizawaliyi Yakoi
Liaoning Technical University
9
Fiona P. Havers
Centers for Disease Control and Prevention
10
Yogesh Sean Gupta
Temple University Hospital

Papers

1
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
MMWR Morbidity and Mortality Weekly Report|2023
316 cit.
2
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
JAMA Internal Medicine|2022
191 cit.
3
Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus — RSV-NET, 12 States, July 2022–June 2023
MMWR Morbidity and Mortality Weekly Report|2023
78 cit.
4
Burden of Respiratory Syncytial Virus–Associated Hospitalizations in US Adults, October 2016 to September 2023
JAMA Network Open|2024
71 cit.
5
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
American Journal of Transplantation|2023
44 cit.
6
Acute Cardiac Events During COVID-19-Associated Hospitalizations
Journal of the American College of Cardiology|2023
36 cit.
7
Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022
MMWR Morbidity and Mortality Weekly Report|2022
33 cit.
8
Potentiate the activity of current antibiotics by naringin dihydrochalcone targeting the AdeABC efflux pump of multidrug-resistant Acinetobacter baumannii
International Journal of Biological Macromolecules|2022
29 cit.
9
Antipersister strategies against stress induced bacterial persistence
Microbial Pathogenesis|2022
25 cit.
10
Post-vaccine epidemiology of serotype 3 pneumococci identifies transformation inhibition through prophage-driven alteration of a non-coding RNA
Genome Medicine|2022
21 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Cynthia G. Whitney
The Task Force for Global Health
2
Keith P. Klugman
Emory University
3
Jeffrey N. Weiser
New York University
4
James C. Paton
The University of Adelaide
5
Elizabeth Miller
Unknown
6
Anne Schuchat
National Center for Injury Prevention and Control
7
Elaine Tuomanen
St. Jude Children's Research Hospital
8
Lyn Finelli
Merck & Co., Inc., Rahway, NJ, USA (United States)
9
Michael J. Fine
University of Pittsburgh
10
Dennis L. Kasper
Harvard University

Papers

1
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
Clinical Infectious Diseases|2007
6.2k cit.
2
A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia
New England Journal of Medicine|1997
4.7k cit.
3
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
American Journal of Respiratory and Critical Care Medicine|2019
3.6k cit.
4
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
New England Journal of Medicine|2015
3.4k cit.
5
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
Cell|2005
2.9k cit.
6
A microbial symbiosis factor prevents intestinal inflammatory disease
Nature|2008
2.3k cit.
7
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Clinical Infectious Diseases|2000
2.3k cit.
8
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
New England Journal of Medicine|2003
2.2k cit.
9
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
New England Journal of Medicine|2015
1.8k cit.
10
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009
New England Journal of Medicine|2009
1.7k cit.

Reagents for Pneumonia and Respiratory Infections

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

CD74 (F6K1S) Rabbit Monoclonal Antibody

#70167$161,376
View Evidence →
Cell Signaling Technology

Phospho-Fgr (Tyr412) (E3R7L) Rabbit Monoclonal Antibody

#38013$176,415
View Evidence →
Cell Signaling Technology

KK-LC-1 (F3U6C) Rabbit Monoclonal Antibody (BSA and Azide Free)

#29342$865
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 67

Acetyl-CoA Carboxylase 2 (D5B9) Rabbit Monoclonal Antibody

#8578$161,351
View Evidence →
Cell Signaling TechnologyEvidence 64

LIMP-2/SCARB2 (E2Z5F) Rabbit Monoclonal Antibody

#27960$160,351
View Evidence →
Cell Signaling TechnologyEvidence 66

IRF-9 (D9I5H) Rabbit Monoclonal Antibody (BSA and Azide Free)

#74423$865
View Evidence →